Karen Firestone - 15 Dec 2023 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
15 Dec 2023
Net transactions value
+$59,880
Form type
4
Filing time
19 Dec 2023, 16:37:26 UTC
Previous filing
12 Jun 2023
Next filing
07 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Purchase $59,880 +4,000 +400% $14.97 5,000 15 Dec 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.